(S (NP-SBJ (NN I) (NN kappa) (NN (MAD-3 B))) (VP-COOD (VP (VBZ masks) (NP (NP (DT the) (JJ nuclear) (NN localization) (NN signal)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN p65))))) (CC and) (VP (VBZ requires) (S (NP-SBJ (DT the) (NN transactivation) (NN domain)) (VP (TO to) (VP (VB inhibit) (NP (NN NF-kappa) (NN B) (NN p65) (NN DNA) (NN binding))))))) (. .))
(S (NP-SBJ-1 (NP (DT The) (JJ active) (JJ nuclear) (NN form)) (PP (IN of) (NP (DT the) (NN NF-kappa) (NN B) (NN transcription) (NN factor) (NN complex)))) (VP (VBZ is) (VP (VBN composed) (NP (-NONE- *-1)) (PP (IN of) (NP (NP (NP (CD two) (NN DNA) (NN binding) (NNS subunits)) (, ,) (NP-COOD (NP (NN NF-kappa) (NN B) (NN p65)) (CC and) (NP (NN NF-kappa) (NN B) (NN p50))) (, ,)) (SBAR (WHNP-2 (NP (DT both)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ (-NONE- *T*-2)) (VP (VBP share) (NP (JJ extensive) (JJ N-terminal) (NN sequence) (NN homology)) (PP (IN with) (NP (DT the) (NN v-rel) (NN oncogene) (NN product)))))))))) (. .))
(S (NP-SBJ (DT The) (NN NF-kappa) (NN B) (NN p65) (NN subunit)) (VP-COOD (VP (VBZ provides) (NP (DT the) (NN transactivation) (NN activity)) (PP (IN in) (NP (DT this) (JJ complex)))) (CC and) (VP (VBZ serves) (PP (IN as) (NP (NP (DT an) (JJ intracellular) (NN receptor)) (PP (IN for) (NP (NP (DT a) (JJ cytoplasmic) (NN inhibitor)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (, ,) (VP (VBN termed) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN I) (NN kappa) (NN B)))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-3 (NP (NN NF-kappa) (NN B) (NN p50)) (ADVP (RB alone))) (VP-COOD (VP (VBZ fails) (S (NP-SBJ (-NONE- *-3)) (VP (TO to) (VP (VB stimulate) (NP (ADJP (NN kappa) (JJ B-directed)) (NN transcription)))))) (, ,) (CC and) (VP (PP (VBN based) (PP (IN on) (NP (JJ prior) (ADJP (FW in) (FW vitro)) (NNS studies)))) (, ,) (VP (VBZ is) (RB not) (ADVP (RB directly)) (VP (VBN regulated) (NP (-NONE- *-3)) (PP (IN by) (NP-LGS (NN I) (NN kappa) (NN B))))))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (JJ molecular) (NN basis)) (PP (IN for) (NP (NP (DT the) (JJ critical) (JJ regulatory) (NN interaction)) (PP (IN between) (NP-COOD (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN I) (NN kappa) (NN (MAD-3 B))))))))))) (, ,) (NP-SBJ-5 (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (JJ human) (NN NF-kappa) (NN B) (NN p65) (NNS mutants)) (SBAR (-NONE- *ICH*-6)))))) (VP (VBD was) (VP (VBN identified) (NP (-NONE- *-5)) (SBAR-6 (WHNP-7 (WDT that)) (S (NP-SBJ (-NONE- *T*-7)) (ADVP (RB functionally)) (VP (VBD segregated) (NP (NP-COOD (NP (NN DNA) (NN binding)) (, ,) (NP (ADJP (NN I) (NN kappa) (JJ B-mediated)) (NN inhibition)) (, ,) (CC and) (NP (ADJP (NN I) (NN kappa) (JJ B-induced)) (JJ nuclear) (NN exclusion))) (PP (IN of) (NP (DT this) (NN transcription) (NN factor))))))))) (. .))
(S (S (NP-SBJ (NP (NNS Results)) (PP (IN from) (NP (NP (ADJP (FW in) (FW vivo)) (NN expression) (NNS studies)) (VP (VBN performed) (NP (-NONE- *)) (PP (IN with) (NP (DT these) (NN NF-kappa) (NN B) (NN p65) (NNS mutants))))))) (VP (VBD revealed) (NP (DT the) (NN following))) (: :)) (S-COOD (S (LST (LS 1) (-RRB- -RRB-)) (NP-SBJ (NN I) (NN kappa) (NN (MAD-3 B))) (ADVP (RB completely)) (VP (VBZ inhibits) (NP (NP (ADJP (NN NF-kappa) (NN B) (JJ p65-dependent)) (JJ transcriptional) (NN activation)) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN through) (NP (NP (DT the) (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (NN kappa) (NN B) (NN enhancer)) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes))))))))) (, ,) (S (LST (LS 2) (-RRB- -RRB-)) (NP-SBJ (NP (DT the) (NN binding)) (PP (IN of) (NP (NN I) (NN kappa) (NN (MAD-3 B)))) (PP (TO to) (NP (NN NF-kappa) (NN B) (NN p65)))) (VP (VBZ is) (ADJP-PRD (JJ sufficient) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB retarget) (NP (NN NF-kappa) (NN B) (NN p65)) (PP (IN from) (NP (DT the) (NN nucleus))) (PP (TO to) (NP (DT the) (NN cytoplasm))))))))) (, ,) (S (LST (LS 3) (-RRB- -RRB-)) (NP-SBJ (NP (JJ selective) (NN deletion)) (PP (IN of) (NP (NP (DT the) (JJ functional) (JJ nuclear) (NN localization) (NN signal)) (ADJP (JJ present) (PP (IN in) (NP (NP (DT the) (NN Rel) (NN homology) (NN domain)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN p65))))))))) (VP (VBZ disrupts) (NP (PRP$ its) (NN ability) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB engage) (NP (NN I) (NN kappa) (NN (MAD-3 B))))))))) (, ,) (CC and) (S (LST (LS 4) (-RRB- -RRB-)) (NP-SBJ (NP (DT the) (JJ unique) (NN C-terminus)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN p65)))) (VP-COOD (VP (VBZ attenuates) (NP (PRP$ its) (JJ own) (JJ nuclear) (NN localization))) (CC and) (VP (VBZ contains) (NP (NP (NNS sequences)) (SBAR (WHNP-9 (WDT that)) (S (NP-SBJ-10 (-NONE- *T*-9)) (VP (VBP are) (VP (VBN required) (NP (-NONE- *-10)) (PP (IN for) (NP (NP (ADJP (NN I) (NN kappa) (JJ B-mediated)) (NN inhibition)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN p65) (NN DNA) (NN binding) (NN activity))))))))))))) (. .)))
(S (ADVP (RB Together)) (, ,) (NP-SBJ (DT these) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NP-COOD (NP (JJ nuclear) (NN localization) (NN signal)) (CC and) (NP (NN transactivation) (NN domain)))) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN p65)))) (VP (VBP constitute) (NP (NP (DT a) (JJ bipartite) (NN system)) (SBAR (WHNP-11 (WDT that)) (S (NP-SBJ-12 (-NONE- *T*-11)) (VP (VBZ is) (ADVP (RB critically)) (VP (VBN involved) (NP (-NONE- *-12)) (PP (IN in) (NP (NP (DT the) (JJ inhibitory) (NN function)) (PP (IN of) (NP (NN I) (NN kappa) (NN (MAD-3 B))))))))))))))) (. .))
(S (ADVP (RB Unexpectedly)) (, ,) (NP-SBJ (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (ADVP (RB also)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NN I) (NN kappa) (NN (MAD-3 B))) (VP (VBZ binds) (ADVP (RB directly)) (PP (TO to) (NP (NN NF-kappa) (NN B) (NN p50))))))) (. .))
(S (NP-SBJ (DT This) (NN interaction)) (VP (VBZ is) (ADJP-PRD (JJ functional)) (SBAR (IN as) (S (NP-SBJ (PRP it)) (VP (VBZ leads) (PP (TO to) (NP (NP (NN retargeting)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN p50))) (PP (IN from) (NP (DT the) (NN nucleus))) (PP (TO to) (NP (DT the) (NN cytoplasm))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-13 (NP (DT no) (NN loss)) (PP (IN of) (NP (NN DNA) (NN binding) (NN activity)))) (VP (VBZ is) (VP (VBN observed) (NP (-NONE- *-13)) (, ,) (S (NP-SBJ (-NONE- *)) (ADVP (RB presumably)) (VP (VBG reflecting) (NP (NP (DT the) (JJ unique) (JJ C-terminal) (NN domain)) (SBAR (WHNP-14 (WDT that)) (S (NP-SBJ (-NONE- *T*-14)) (VP (VBZ is) (ADJP-PRD (JJ distinct) (PP (IN from) (NP (NP (DT that)) (ADJP (JJ present) (PP (IN in) (NP (NN NF-kappa) (NN B) (NN p65))))))))))))))) (. .))
